跳至主要内容
临床试验/CTRI/2017/12/010736
CTRI/2017/12/010736招募中4 期

A randomised placebo-controlled study to compare the safety and efficacy of sildenafil mono therapy with combination therapy of ambrisentan and sildenafil in pulmonary hypertension including eisenmenger syndrome

PGIMER Chandigarh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with primary pulmonary hypertension and eisenmenger syndrome will be included
  • Without Comorbid hepatic or renal diseases

排除标准

  • 1.Secondary causes of pulmonary hypertension
  • 2. Comorbid hepatic and renal conditions
  • 3.Patients with coronary artery disease
  • 4.Patients with contraindications to the drugs

研究者

相似试验